WFS1 Antikörper (N-Term)
-
- Target Alle WFS1 Antikörper anzeigen
- WFS1 (Wolfram Syndrome 1 (WFS1))
-
Bindungsspezifität
- N-Term
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser WFS1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Immunoprecipitation (IP), Immunocytochemistry (ICC)
- Spezifität
- Reacts with human, rat and mouse 100 kDa WFS1 protein
- Aufreinigung
- Antiserum
- Immunogen
- A 110 amino acid region of the N-terminal region of the human WFS1 protein.
-
-
- Applikationshinweise
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only :
ICC/IF1:200 IHC1:1000 IP2 μL WB1:500 - 1:2000 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Lagerung
- -20 °C/-80 °C
- Informationen zur Lagerung
- Aliquot and store at -20°C or -80°C. Avoid freeze-thaw cycles.
-
- Target
- WFS1 (Wolfram Syndrome 1 (WFS1))
- Andere Bezeichnung
- Wolframin (WFS1 Produkte)
- Synonyme
- WFRS antikoerper, WFS antikoerper, WFSL antikoerper, CG4917 antikoerper, Dmel\\CG4917 antikoerper, GB15257 antikoerper, WFS1 antikoerper, AI481085 antikoerper, wolframin antikoerper, wfs1 antikoerper, wolframin ER transmembrane glycoprotein antikoerper, wolfram syndrome 1 antikoerper, wolframin antikoerper, Wolfram syndrome 1 (wolframin) L homeolog antikoerper, Wfs1 antikoerper, WFS1 antikoerper, wfs1 antikoerper, LOC552818 antikoerper, CpipJ_CPIJ013087 antikoerper, wfs1.L antikoerper
- Hintergrund
- Wolframin is involved in negative regulation of apoptosis and is a key component of theWolfram syndrome 1 an insulin metabolic disorder affecting young people.
- Pathways
- Sensory Perception of Sound, Carbohydrate Homeostasis, ER-Nucleus Signaling, Negative Regulation of intrinsic apoptotic Signaling, SARS-CoV-2 Protein Interaktom
-